CooperSurgical has acquired ZyMōt Fertility, a subsidiary of DxNow, Inc. Read the full announcement here.
-
Wallace®
Over 35 years ago, Wallace worked with IVF pioneers to design and manufacture the world’s first commercially available embryo transfer…
-
ERBiome℠ Test
Determining the optimal endometrial environment CooperSurgical’s ERBiome℠ test evaluates your patient’s endometrial microbiome to guide your personalized treatment strategy. ERBiome…
-
ER-Peak℠ Test
Determining the peak endometrial receptivity CooperSurgical’s ERPeak℠ test identifies the best day to transfer an embryo by measuring the expression…
-
ER-Complete℠
Right Time, Right Environment Three simple results from one endometrial biopsy helps to provide you with the optimal time for…
-
ER-Complete℠ Test
3-in-1 test for optimal endometrium and embryo transfer Three simple results from one endometrial biopsy help to provide you with…
-
PGTai℠ Technology Platform
AI technology for embryo selection Since its launch in 2018, over 350,000 embryos have been tested with our robust PGTaiSM test1 shown to…
-
PGT-SR
Detecting Chromosomal Rearrangement Using our PGTaiSM technology, we perform PGT-SR for patients with high accuracy. Our pioneering AI analysis is…
-
PGT-M
Fast-Track PGT-M℠ Testing: Empowering Families and Clinicians Leveraging cutting-edge amplification technology to provide a new premium Fast-Track PGT-M service. What to…